Amberen Overview

  • Year Founded
  • 2006

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $110M

Amberen General Information

Description

Developer of a supplement product intended to provide menopause relief. The company's product is a clinically tested and estrogen-free supplement that helps to relieve common menopause symptoms like hot flashes, night sweats, mood swings, low sex drive, etc. and helps to maintain and restore hormonal balance, enabling women to get a safe and effective menopause solution.

Contact Information

Website
www.amberen.com
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Corporate Office
  • Post Office Box 1337
  • El Segundo, CA 90245
  • United States
+1 (800)
Primary Industry
Pharmaceuticals
Parent Company
Alliance Pharma
Corporate Office
  • Post Office Box 1337
  • El Segundo, CA 90245
  • United States
+1 (800)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Amberen Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 29-Dec-2020 $110M Completed Generating Revenue
1. Seed Round 15-Oct-2019 Completed Generating Revenue
To view Amberen’s complete valuation and funding history, request access »

Amberen Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a supplement product intended to provide menopause relief. The company's product is a clinically tested and
Pharmaceuticals
El Segundo, CA

Princeton, NJ
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Amberen Competitors (1)

One of Amberen’s competitors is MenoLabs, a Corporate Backed or Acquired company based in Princeton, NJ.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
MenoLabs Corporate Backed or Acquired Princeton, NJ
You’re viewing 1 of 1 competitors. Get the full list »

Amberen Patents

  • 2

    Total Documents Applications and Grants

  • Total Patents Families

  • 2

    Granted

  • Pending

  • Expiring in next 12 mo

Amberen Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20210161940-A1 Method and agent for lowering total cholesterol levels and for improving blood lipid spectrum composition Active 27-Apr-2018
US-11213542-B2 Method and agent for lowering total cholesterol levels and for improving blood lipid spectrum composition Active 27-Apr-2018

Ready to get started?

Request a free trial

Amberen FAQs

  • When was Amberen founded?

    Amberen was founded in 2006.

  • Where is Amberen headquartered?

    Amberen is headquartered in El Segundo, CA.

  • What industry is Amberen in?

    Amberen’s primary industry is Pharmaceuticals.

  • Is Amberen a private or public company?

    Amberen is a Private company.

  • What is the current valuation of Amberen?

    The current valuation of Amberen is .

  • What is Amberen’s current revenue?

    The current revenue for Amberen is .

  • How much funding has Amberen raised over time?

    Amberen has raised $2M.

  • Who are Amberen’s competitors?

    MenoLabs is a competitor of Amberen.

  • When was Amberen acquired?

    Amberen was acquired on 29-Dec-2020.

  • Who acquired Amberen?

    Amberen was acquired by Alliance Pharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »